Post by Nova Eye Medical

In this month's "Industry Insider" feature of Ophthalmology Management our President Joe Bankovich discusses the rebirth of our business as Nova Eye Medical - and our commitment to develop a comprehensive portfolio of #glaucoma treatment technologies that advance clinical outcomes and enhance patient quality of life. "The acquisition of the Molteno3 signals a step forward in our stated strategy to build a comprehensive portfolio of glaucoma treatment technologies. From the proprietary process of staged bleb formation to a simplified surgical procedure, Molteno3 is a game-changer." Read the full interview here: https://lnkd.in/gp36EYF (page 62)